Immuron Ltd. (@ImmuronLtd) header
Immuron Ltd. (@ImmuronLtd) profile picture

Immuron Ltd.

@ImmuronLtd

Publicly listed biopharma company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system & gut microbiome

 Australia, USA and Canada
immuron.com.au/
Joined February 2017
  • Tweets860
  • Following312
  • Followers406
34Media
Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)Photo by Immuron Ltd. (@ImmuronLtd)
We've just released the following announcement: Emerging Growth Conference Presentation Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Emerging Growth Conference Presentation

ASX:IMC - Emerging Growth Conference Presentation

Read and interact with this announcement: Emerging Growth Conference Presentation on Immuron's investor hub

investors.immuron.com.au
28
9% sales lift to $2.2M in Q1 FY27 as @ImmuronLtd Travelan grows 14% in Australia $IMC stockwirex.com/asx-stock-new…
Immuron Posts $2.2M Q1 FY27 Sales as Travelan Relaunch Lifts Australia 14%

Immuron Posts $2.2M Q1 FY27 Sales as Travelan Relaunch Lifts Australia 14%

Immuron Ltd lifts Q1 FY27 revenue 9% to $2.2M as Travelan sales surge 14% in Australia. Read the full update.

stockwirex.com
1
1
96
Immuron posted $2.2M sales in Q1 FY27 as Travelan outsold Imodium in pharmacy, per @ImmuronLtd $IMC Visit stockwirex.com/asx-stock-new…
1
1
106
We've just released the following announcement: Immuron FY27 Sales Update Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Immuron FY27 Sales Update

ASX:IMC - Immuron FY27 Sales Update

Read and interact with this announcement: Immuron FY27 Sales Update on Immuron's investor hub

investors.immuron.com.au
33
$IMRN $IMC Live Emerging Growth Conference 97 - October 28 & 29 @ImmuronLtd Register: goto.webcasts.com/starthere.… Questions for the Company? [email protected] To Present on the Conference: 305-330-1985 [email protected]
Image from Emerging Growth Conference (@EmergingGrowthC)
4
6
216
We've just released the following announcement: Notice of Annual General Meeting and Proxy Form Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Notice of Annual General Meeting and Proxy Form

ASX:IMC - Notice of Annual General Meeting and Proxy Form

Read and interact with this announcement: Notice of Annual General Meeting and Proxy Form on Immuron's investor hub

investors.immuron.com.au
34
50% fewer ETEC adverse events in @ImmuronLtd Travelan study published in Scientific Reports $IMC stockwirex.com/asx-stock-new…
Immuron's Travelan Trial Published in Scientific Reports Despite Missed Endpoints

Immuron's Travelan Trial Published in Scientific Reports Despite Missed Endpoints

Immuron Ltd's Travelan Phase 2 trial is now published in Scientific Reports despite missed endpoints. Read the details.

stockwirex.com
1
1
130
Travelan data shows 50% fewer adverse events vs placebo as @ImmuronLtd misses primary endpoints $IMC Visit stockwirex.com/asx-stock-new…
1
1
119
We've just released the following announcement: Travelan Phase 2 Study Results Published Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Travelan Phase 2 Study Results Published

ASX:IMC - Travelan Phase 2 Study Results Published

Read and interact with this announcement: Travelan Phase 2 Study Results Published on Immuron's investor hub

investors.immuron.com.au
30
We've just released the following announcement: Annual Report Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Annual Report

ASX:IMC - Annual Report

Read and interact with this announcement: Annual Report on Immuron's investor hub

investors.immuron.com.au
41
We've just released the following announcement: Presentation to Coffee Microcaps Conference Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - Presentation to Coffee Microcaps Conference

ASX:IMC - Presentation to Coffee Microcaps Conference

Read and interact with this announcement: Presentation to Coffee Microcaps Conference on Immuron's investor hub

investors.immuron.com.au
46
Immuron Ltd. retweeted
CMicrocaps (@CMicrocaps) profile picture
CMicrocaps@CMicrocapsSep 17
Don’t forget to get your ticket for the Sydney conference next Tuesday 22nd of September. #asx #microcap
Image from CMicrocaps (@CMicrocaps)
2
5
576
Immuron Ltd. retweeted
CMicrocaps (@CMicrocaps) profile picture
CMicrocaps@CMicrocapsSep 14
Tickets for the Coffee Microcaps Sydney Conference happening on Tuesday, 22nd of September, are on sale via @humanitix_team. #asx #microcap Many thanks to @DMXAsset for sponsoring the event. @evehealthgroup @raizaustralia @SwiftNetworksAu @nobleoaklife @ImmuronLtd
Image from CMicrocaps (@CMicrocaps)
3
1
6
1,561
Immuron Limited (ASX:IMC) (NASDAQ:IMRN) has announced an exclusive distribution agreement with Calmino Group AB to bring PROIBS to the United States. zurl.co/9PtYR #ASX #NASDAQ #IMC #KalkineMediaAU
Image from Kalkine Media Australia (@kalkineau)
1
2
83
94% user efficacy as @ImmuronLtd secures exclusive US PROIBS® distribution rights $IMC stockwirex.com/asx-stock-new…
Immuron Ltd Secures Exclusive US Distribution Rights for PROIBS in $4.16B Market

Immuron Ltd Secures Exclusive US Distribution Rights for PROIBS in $4.16B Market

Immuron Ltd secures exclusive US distribution rights for PROIBS® in a $4.16B gut health market. What it means for IMC investors.

stockwirex.com
1
1
139
Immuron Ltd. retweeted
Bold Investors ASX (@Bold_ASX) profile picture
Bold Investors ASX
@Bold_ASXSep 4
Replying to @ImmuronLtd
@ImmuronLtd (#ASX: $IMC) Secures Exclusive PROIBS US Distribution Deal #IBS boldinvestors.com.au/news/im…
Immuron (ASX: IMC) Secures PROIBS US Distribution

Immuron (ASX: IMC) Secures PROIBS US Distribution

Immuron signs an exclusive agreement with Calmino to distribute digestive-health medical device PROIBS in the US market.

boldinvestors.com.au
2
3
115
We've just released the following announcement: PROIBS US Distribution Agreement Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - PROIBS US Distribution Agreement

ASX:IMC - PROIBS US Distribution Agreement

Read and interact with this announcement: PROIBS US Distribution Agreement on Immuron's investor hub

investors.immuron.com.au
2
71
$7.7m revenue and $9.0m cash as @ImmuronLtd posted 6% full-year sales growth and $6.2m cash improvement in FY26 $IMC stockwirex.com/asx-stock-new…
Immuron Ltd Posts Record $7.7M FY26 Revenue as Cash Rises to $9.0M

Immuron Ltd Posts Record $7.7M FY26 Revenue as Cash Rises to $9.0M

Immuron Ltd reports record $7.7M revenue and $9M cash in FY26 results. Losses narrow as IMM-529 IND approved. Read the full update.

stockwirex.com
1
1
120
We've just released the following announcement: FY26 Results Presentation Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
ASX:IMC - FY26 Results Presentation

ASX:IMC - FY26 Results Presentation

Read and interact with this announcement: FY26 Results Presentation on Immuron's investor hub

investors.immuron.com.au
62
We've just released the following announcement: Emerging Growth Conference Presentation Check out the full announcement and join in with the conversation at: investors.immuron.com.au/ann… #imc
70
Load more